Welcome to Advanced Search

Models

About 181 results
Literature

ZFP91 disturbs metabolic fitness and antitumor activity of tumor-infiltrating T cells

Model Organisms:小鼠 Product & Service:Zfp91-floxed Research field:T cell

Literature

An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to...

Model Organisms:小鼠 Product & Service:Il2rg Research field:immunity

Literature

Endothelial CDS2 Deficiency Causes VEGFA-mediated Vascular Regression and Tumor Inhibition

Model Organisms:Mouse Product & Service:cds2 Research field:Vascular Regression

Literature

Genetic Fate Mapping of Transient Cell Fate Reveals N-Cadherin Activity and Function in Tumor Metastasis

Model Organisms:Mouse Product & Service:Vim LSL-Dre;N-cad-LSL-Dre Research field:lineage tracing, Tumor metastasis

Literature

Self-assembly of X-shaped antibody to combine the activity of IgG and IgA for enhanced tumor killing

Model Organisms:小鼠 Product & Service:hCD89&hFCRN Research field:immunity

Literature
Pages

New Service Launch: Mouse Bone Metastasis Cancer Model and Pain-Related Behavior Assessment!

Bone metastasis cancer model Pain-related behavior assessment Cancer-induced bone pain Bone cancer pain models Mouse bone metastasis model Animal models in cancer research Cancer research services Bone metastasis in mice Pain management in cancer

We are excited to announce that GenoBioTX has launched a new service featuring mouse bone metastasis cancer models and pain-related behavior assessment, designed to support cancer research and pain management effectively.

Pages

Advancing Cancer Therapy: Harnessing In Vivo Tumor Models for Breakthrough Drug Development

Cancer therapy advancements In vivo tumor models Preclinical cancer research Drug development in oncology Gene-modified cell lines Immuno-oncology Tumor modeling for drug discovery Cancer drug development Animal modeling services Cancer drug preclinical models

Join us for an insightful webinar exploring the critical role of in vivo tumor models in advancing cancer drug therapy. We will provide an overview of the diverse tumor models developed by our company, highlighting case studies demonstrating their effectiveness in preclinical cancer research. The session will delve into the comprehensive use of gene-modified cell lines and genetically modified spontaneous mouse models, showcasing their application in mimicking human cancer biology. We will conclude with a brief introduction to our company and our commitment to accelerating cancer drug development through innovative animal modeling services.

Pages

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Email Back to top